化学发光法及胶乳免疫比浊法检测FDP和D-二聚体的方法学比对及偏倚评估

李玉琼, 彭易怡, 徐阳, 陈家进, 汤旭东, 任碧琼

湖南师范大学学报医学版 ›› 2026, Vol. 23 ›› Issue (3) : 127-132.

PDF(2669 KB)
PDF(2669 KB)
湖南师范大学学报医学版 ›› 2026, Vol. 23 ›› Issue (3) : 127-132.
检验医学

化学发光法及胶乳免疫比浊法检测FDP和D-二聚体的方法学比对及偏倚评估

  • 李玉琼1, 彭易怡1, 徐阳1, 陈家进1, 汤旭东2, 任碧琼1,3
作者信息 +

Method Comparison and Bias Estimation between Chemiluminescence Immunoassay and Latex-Enhanced Immunoturbidimetric Assay for Detecting FDP and D-Dimer

  • LI Yuqiong1, PENG Yiyi1, XU Yang1, CHEN Jiajin1, TANG Xudong2, REN Biqiong1,3
Author information +
文章历史 +

摘要

目的 以美国临床和实验室标准化协会(clinical and laboratory standards institute,CLSI)EP09c指南为标准,评价化学发光方法及胶乳免疫比浊法检测患者血浆纤维蛋白(原)降解产物(fibrin/fibrinogen degradation products,FDP)和D-二聚体(D-dimer,DD)之间的可比性及偏倚,为不同方法检测FDP、DD结果互认提供参考依据。方法 以胶乳免疫比浊法为参比方法(X),化学发光法为试验方法(Y),选择Passing-Bablok回归对结果进行线性拟合,分别计算其在选定浓度水平处的偏倚,以1/2 允许总误差(total allowable error,TEa)(国家卫生健康委临床检验中心室间质量评审允许总误差)为评判标准,对检测结果进行方法学比对及偏倚评估,并对两种方法测量程序的关联性、一致性和优势性进行评估。结果 化学发光法检测FDP在5.0 mg/L处的偏倚为-9.59%(<17.5%)、DD在0.5 mg/L处的偏倚为14.29%(<25.0%),均在可接受范围内。DD和FDP的χ2检验结果均提示两种方法测定结果存在关联(P<0.001);FDP的Kappa检验结果为k=0.66(P<0.001),DD的Kappa检验结果为k=0.85(P<0.001),均提示具有良好的一致性,McNemar检验显示两方法学之间的差异无统计学意义(P>0.05),两种测量程序具有可比性。结论 两方法检测FDP及DD的测量程序具有良好的一致性及相关性,临床参考范围上限处的偏倚在可接受范围内,能够满足临床检测要求,一定范围内可以互认。

Abstract

Objective Using the CLSI EP09c guideline as the standard, this study evaluated the comparability and bias of measurement procedures for detecting fibrin/fibrinogen degradation products (FDP) and D-dimers (DD) in plasma using chemiluminescence and latex immunoturbidimetry methods, providing a reference basis for mutual recognition of FDP and DD results obtained using different methods. Methods Latex immunoturbidimetry was used as the reference method (X) and chemiluminescence immunoassay as the test method (Y). Passing-Bablok regression was used to perform linear fitting of the results, and the bias at the selected concentration levels was calculated separately. Using 1/2 TEa (the total allowable error permitted by the National Health Commission Clinical Laboratory Center's interlaboratory quality assessment) as the evaluation criterion, the test results were subjected to methodological comparison and bias assessment, and the correlation, consistency, and superiority of the two measurement procedures were assessed. Results The bias of chemiluminescence method was -9.59% (<17.5%) for FDP at 5.0 mg/L and 14.29% (<25.0%) for DD at 0.5 mg/L, both within acceptable ranges. The chi-square test results of DD and FDP showed that the two methods had a good correlation (P<0.001), The Kappa test results of FDP were k=0.66(P<0.001) and the Kappa test of DD was k=0.85(P<0.001), both indicating good agreement, and the McNemar test showed no significant difference between the two methodologies (P>0.05), and the two measurement procedures were comparable. Conclusion The measurement procedures for FDP and DD using the two methods show good consistency and correlation. The bias at the upper limit of the clinical reference range is within an acceptable range, meeting clinical testing requirements, and mutual recognition is possible within a certain range.

关键词

EP09c / 纤维蛋白降解产物 / D-二聚体 / 化学发光法 / 胶乳免疫比浊法 / 测量程序

Key words

EP09c / fibrin degradation products / D-Dimer / chemiluminescence method / latex immunoturbidimetry / measurement procedure

引用本文

导出引用
李玉琼, 彭易怡, 徐阳, 陈家进, 汤旭东, 任碧琼. 化学发光法及胶乳免疫比浊法检测FDP和D-二聚体的方法学比对及偏倚评估[J]. 湖南师范大学学报医学版. 2026, 23(3): 127-132
LI Yuqiong, PENG Yiyi, XU Yang, CHEN Jiajin, TANG Xudong, REN Biqiong. Method Comparison and Bias Estimation between Chemiluminescence Immunoassay and Latex-Enhanced Immunoturbidimetric Assay for Detecting FDP and D-Dimer[J]. Journal of Hunan Normal University(Medical Science). 2026, 23(3): 127-132
中图分类号: R446.11   

参考文献

[1] FRANCHINI M, FOCOSI D, PEZZO MP, et al.How we manage a high D-dimer[J]. Haematologica, 2024, 109(4): 1035-1045.
[2] CHEN Y, ZHANG S, ZENG Q, et al.Plasma fibrinogen, D-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis[J]. Sci Rep, 2021, 11: 16846.
[3] ZHU B, ZHANG L, DU W, et al.Levels of fibrin degradation products at admission with acute ischemic stroke correlate with the NIH stroke scale score 1 h after intravenous thrombolysis[J]. Front Neurol, 2021, 12: 651867.
[4] 王梦园, 刘家敏. D-二聚体与纤维蛋白原对急性脑卒中患者静脉溶栓预后的预测价值[J]. 现代医学与健康研究电子杂志, 2025, 9(17): 100-103.
[5] HORIUCHI H, MORISHITA E, URANO T, et al.COVID-19-related thrombosis in Japan: final report of a questionnaire-based survey in 2020[J]. J Atheroscler Thromb, 2021, 28(4): 406-416.
[6] DONG W, TANG Y, LEI M, et al.The effect of perioperative sequential application of multiple doses of tranexamic acid on postoperative blood loss after PLIF: a prospective randomized controlled trial[J]. Int J Surg, 2024, 110(4): 2122-2133.
[7] 欧元祝, 陈宝荣, 居漪. 临床化学检测的标准化现状[J]. 检验医学, 2021, 36(3): 240-244.
[8] CLSI. Measurement procedure comparison and bias estimation using patient samples[S]. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2018.
[9] BEVAN S, LONGSTAFF C.Is it possible to make a common reference standard for D-dimer measurements? Communication from the ISTH SSC subcommittee on fibrinolysis[J]. J Thromb Haemost, 2022, 20(2): 498-507.
[10] WAUTHIER L, FAVRESSE J, HARDY M, et al.D-dimer testing: A narrative review[J]. Adv Clin Chem, 2023, 114: 151-223.
[11] FOLSOM AR, GOTTESMAN RF, APPIAH D, et al.Plasma d-dimer and incident ischemic stroke and coronary heart disease: The Atherosclerosis Risk in Communities Study[J]. Stroke, 2016, 47(1): 18-23.
[12] SIMES J, ROBLEDO KP, WHITE HD, et al.D-dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease: LIPID Study[J]. Circulation, 2018, 138(7): 712-723.
[13] DI NISIO M, VAN ES N, BÜLLER H R. Deep vein thrombosis and pulmonary embolism[J]. Lancet, 2016, 388(10063): 3060-3073.
[14] JOHNSON ED, SCHELL JC, RODGERS GM.The D-dimer assay[J]. Am J Hematol, 2019, 94(7): 833-839.
[15] FREUND Y, CHAUVIN A, JIMENEZ S, et al.Effect of a diagnostic strategy using an elevated and age-adjusted D-dimer threshold on thromboembolic events in emergency department patients with suspected pulmonary embolism: A randomized clinical trial[J]. JAMA, 2021, 326(21): 2141-2149.
[16] VAN ES N, TAKADA T, KRAAIJPOEL N, et al.Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis[J]. Eur Heart J, 2023, 44(32): 3073-3081.
[17] SUZUKI T, DISTANTE A, ZIZZA A, et al.Diagnosis of acute aortic dissection by D-dimer: the international registry of acute aortic dissection substudy on biomarkers (IRAD-Bio) experience[J]. Circulation, 2009, 119(20): 2702-2707.
[18] SODECK G, DOMANOVITS H, SCHILLINGER M, et al.D-dimer in ruling out acute aortic dissection: a systematic review and prospective cohort study[J]. Eur Heart J, 2007, 28(24): 3067-3075.
[19] 王欢, 徐令清, 朱振杰. 乳胶增强免疫比浊法与电化学发光法检测降钙素原的对比分析[J]. 吉林医学, 2018, 39(8): 1410-1413.
[20] 中国研究型医院学会血栓与止血专业委员会. D-二聚体实验室检测与临床应用中国专家共识[J]. 中华医学杂志, 2023, 103(35): 2743-2756.

基金

湖南省科技创新计划项目“Treg联合DAMPS在急性缺血性脑卒中患者诊治中的临床应用价值研究”(2021SK50801); 2024年中国高校产学研创新基金 “国产化学发光检测系统细胞因子成人参考区间的建立以及DD、FDP不同方法检验结果互认的探索”(2024DR037)

PDF(2669 KB)

Accesses

Citation

Detail

段落导航
相关文章

/

〈 〉